ADNI | Publications

Filter results by:

1800 Total Publications

Functional activity maps based on significance measures and Independent Component Analysis.
Martínez-Murcia, F. J., Górriz, J. M., Ramírez, J., Puntonet, C. G., & Illán, I. a.
2013; Journal Computer Methods and Programs in Biomedicine; vol. 111; no. 1; pp. 255-68; AWUVIqi8dzjauPDbjhq- doi:10.1016/j.cmpb.2013.03.015

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease.
Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., & Sauer, H.
2013; Journal PloS One; vol. 8; no. 6; pp. e67346; AWUVIqi8dzjauPDbjhrP doi:10.1371/journal.pone.0067346

CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer’s disease.
Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.
2013; Journal Acta Neuropathologica; vol. 126; no. 5; pp. 683-697; AWUU_d3HdzjauPDbjhqb doi:10.1007/s00401-013-1148-z

Sample size estimates for well-powered cross-sectional cortical thickness studies.
Pardoe, H. R., Abbott, D. F., Jackson, G. D., & Initiative, A. D. N.
2013; Journal Human Brain Mapping; vol. 34; no. 11; pp. 3000-3009; AWUU_d3HdzjauPDbjhqg doi:10.1002/hbm.22120

α-Synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment.
Ane Korff, PhD, Changqin Liu, MD, PhD, Carmen Ginghina, MD, Min Shi, PhD, and Jing Zhang, MD, PhD, for the Alzheimer’s Disease Neuroimaging Initiative
2013; Journal Journal of Alzheimer's Disease; vol. 36; no. 4; pp. 679-688; AWUU_d3HdzjauPDbjhql

Latent feature representation with stacked auto-encoder for AD/MCI diagnosis.
Suk, H.-I., Lee, S.-W., & Shen, D.
2013; Journal Brain Structure and Function; pp. 1-19; AWUVHdZzdzjauPDbjhqs doi:10.1007/s00429-013-0687-3

Gaussian mixture model-based noise reduction in resting state fMRI data.
Garg, G., Prasad, G., & Coyle, D.
2013; Journal Journal of Neuroscience Methods; vol. 215; no. 1; pp. 71-77; AWUVHdZzdzjauPDbjhqw doi:10.1016/j.jneumeth.2013.02.015

Regional patterns of atrophy on MRI in Alzheimer’s disease: Neuropsychological features and progression rates in the ADNI cohort.
Duara, R., Loewenstein, D. a., Shen, Q., Barker, W., Greig, M. T., Varon, D., … Dickson, D. W.
2013; Journal Advances in Alzheimer's Disease; vol. 2; no. 4; pp. 135-147; AWUVHdZzdzjauPDbjhq2 doi:10.4236/aad.2013.24019

Higher rates of decline for women and apolipoprotein E epsilon4 carriers.
Holland, D., Desikan, R. S., Dale, a M., & McEvoy, L. K.
2013; Journal American Journal of Neuroradiology; vol. 34; no. 12; pp. 2287-93; AWUVHdZzdzjauPDbjhq6 doi:10.3174/ajnr.A3601

White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman, V. a., Carmichael, O. T., Schwarz, C., Tosto, G., Zimmerman, M. E., & Brickman, A. M.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 5; pp. S124-S131; AWUVFyWqwAl_G9zjEvgb doi:10.1016/j.jalz.2012.11.009